CRON

Cronos Group Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth 6/10
  • Value 1/10
Cronos Group sales and earnings growth
CRON Growth
Good
  • Revenue Y/Y 29.22%
  • EPS Y/Y 0.00%
  • FCF Y/Y 519.97%
Cronos Group gross and profit margin trends
CRON Profitability
Neutral
  • Gross margin 42.70%
  • EPS margin -1.10%
  • ROIC 5Y -19.65%
Cronos Group net debt vs free cash flow
CRON Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -1.3

Cronos Group stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks